- Home
- KNSA vs ACLS Comparison
KNSA vs ACLS Comparison
Compare KNSA & ACLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- ACLS
- Stock Information
- Founded
- KNSA 2015
- ACLS 1995
- Country
- KNSA United Kingdom
- ACLS United States
- Employees
- KNSA N/A
- ACLS N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- ACLS Industrial Machinery/Components
- Sector
- KNSA Health Care
- ACLS Technology
- Exchange
- KNSA Nasdaq
- ACLS Nasdaq
- Market Cap
- KNSA 2.6B
- ACLS 2.6B
- IPO Year
- KNSA 2018
- ACLS 2000
- Fundamental
- Price
- KNSA $38.51
- ACLS $84.47
- Analyst Decision
- KNSA Strong Buy
- ACLS Buy
- Analyst Count
- KNSA 7
- ACLS 6
- Target Price
- KNSA $44.00
- ACLS $98.75
- AVG Volume (30 Days)
- KNSA 392.4K
- ACLS 740.2K
- Earning Date
- KNSA 10-28-2025
- ACLS 11-05-2025
- Dividend Yield
- KNSA N/A
- ACLS N/A
- EPS Growth
- KNSA N/A
- ACLS N/A
- EPS
- KNSA 0.07
- ACLS 4.91
- Revenue
- KNSA $529,332,000.00
- ACLS $896,089,000.00
- Revenue This Year
- KNSA $37.21
- ACLS N/A
- Revenue Next Year
- KNSA $12.07
- ACLS $5.64
- P/E Ratio
- KNSA $582.26
- ACLS $17.21
- Revenue Growth
- KNSA 56.18
- ACLS N/A
- 52 Week Low
- KNSA $17.82
- ACLS $40.40
- 52 Week High
- KNSA $39.12
- ACLS $107.23
- Technical
- Relative Strength Index (RSI)
- KNSA 64.65
- ACLS 38.33
- Support Level
- KNSA $37.69
- ACLS $86.04
- Resistance Level
- KNSA $38.83
- ACLS $98.35
- Average True Range (ATR)
- KNSA 0.95
- ACLS 4.21
- MACD
- KNSA 0.00
- ACLS -1.97
- Stochastic Oscillator
- KNSA 79.11
- ACLS 4.22
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About ACLS Axcelis Technologies Inc.
Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.